Spearman correlation analysis of 43 BC patients showed that the incidence of distant metastasis and lymph nodes metastasis significantly increased in HR-negative, HER2-positive, and P53-negative patients (see Table 7 for a better understanding). Here, ERBB2 is linked to breast cancer.